GOLM1 and prostate carcinoma: For example, a novel Golgi protein (GOLPH2)-regulated OA exhibits significant anti-tumor efficacy in hepatocellular carcinoma, liver cancer stem cells, and prostate cancer stem cells [7,8,16].